Issues
-
Cover Image
Cover Image
The longitudinal relaxation rate of protons is increased when subjects switch from breathing air to inhaling 100% oxygen. This effect when detected by MRI scanning is termed oxygen-enhanced MRI. It was found that this technique—in combination with measurements of perfusion—was capable of in vivo mapping of tumor hypoxia, distinguishing tumor subregions with low oxygen tension from well-oxygenated tumor tissue. Pimonidazole adduct formation immunofluorescence was used to validate these findings. Oxygen-enhanced MRI can be performed readily on conventional clinical scanners, so the technique has potential for rapid clinical translation. For details, see article by O’Connor and colleagues on page 787. - PDF Icon PDF LinkTable of Contents
Cancer Research
Table of Contents
Breaking Advances
Cancer Research 75th Anniversary Commentaries
Review
Integrated Systems and Technologies
Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models
Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas
Microenvironment and Immunology
Molecular and Cellular Pathobiology
NADPH Oxidase 1 Activity and ROS Generation Are Regulated by Grb2/Cbl-Mediated Proteasomal Degradation of NoxO1 in Colon Cancer Cells
Therapeutics, Targets, and Chemical Biology
Tumor and Stem Cell Biology
Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell–like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine Circuit
Correction
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.